BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Direct acting antivirals
1
Generic vs brand forms of direct acting antivirals for hepatitis C virus treatment in Egyptian children
12/26/2025 10:27:29 AM | Browse: 35 | Download: 174
2
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?
6/14/2024 8:01:41 AM | Browse: 109 | Download: 396
3
Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?
5/22/2024 11:33:24 AM | Browse: 197 | Download: 694
4
Serum omentin-1 is correlated with the severity of liver disease in patients with chronic hepatitis C
12/25/2023 6:03:15 AM | Browse: 231 | Download: 1398
5
Acute-on-chronic liver failure induced by antiviral therapy for chronic hepatitis C: A case report
10/25/2023 8:49:11 AM | Browse: 339 | Download: 1086
6
Effectiveness and safety of generic and brand direct acting antivirals for the treatment of chronic hepatitis C
12/2/2022 12:50:19 PM | Browse: 512 | Download: 1660
7
Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
6/23/2022 2:39:01 PM | Browse: 601 | Download: 1596
8
Breakthroughs and challenges in the management of pediatric viral hepatitis
5/20/2021 8:38:05 AM | Browse: 702 | Download: 1714
9
Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations
10/12/2018 5:32:21 AM | Browse: 1630 | Download: 2014
10
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 1357 | Download: 1936
11
Successful combination of direct antiviral agents in liver-transplanted patients with recurrent hepatitis C virus
3/26/2018 8:48:04 AM | Browse: 1317 | Download: 2527
12
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
3/4/2018 12:36:47 PM | Browse: 1083 | Download: 1918
13
Efficacy and safety of sofosbuvir and ledipasvir in japanese patients aged 75 years or over with hepatitis C genotype 1
12/27/2017 10:31:19 AM | Browse: 1304 | Download: 2642
14
Improved Hepascore in hepatitis C predicts reversal in risk of adverse outcome
7/5/2017 4:40:08 AM | Browse: 1197 | Download: 2318
15
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C
3/6/2017 3:54:00 PM | Browse: 1572 | Download: 2292
16
Hepatitis C infected patients need vitamin D3 supplementation in the era of direct acting antivirals treatment
2/26/2017 6:20:00 PM | Browse: 1305 | Download: 1847
17
Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment
11/4/2016 10:35:00 AM | Browse: 1371 | Download: 2683
18
Hepatitis C virus: A time for decisions. Who should be treated and when?
1/29/2016 11:06:00 AM | Browse: 1243 | Download: 2771
19
Treatment strategies for chronic hepatitis C prior to and following liver transplantation
1/7/2016 12:14:00 PM | Browse: 1234 | Download: 2022
20
Hepatitis C genotype 4: The past, present, and future
12/4/2015 3:24:00 PM | Browse: 2040 | Download: 2824
21
Era of direct acting antivirals in chronic hepatitis C: Who will benefit?
10/30/2015 11:57:00 AM | Browse: 1687 | Download: 2250
22
Predictive factors associated with hepatitis C antiviral therapy response
6/29/2015 5:40:00 PM | Browse: 1348 | Download: 2295
23
Hepatitis C virus: Virology, diagnosis and treatment
6/3/2015 12:01:00 PM | Browse: 1735 | Download: 2367
24
Hepatitis C: New challenges in liver transplantation
5/20/2015 5:01:00 PM | Browse: 1269 | Download: 2622
25
Impact of all oral anti-hepatitis C virus therapy: A meta-analysis
4/19/2015 5:46:00 PM | Browse: 1242 | Download: 2095
26
Management of patients with hepatitis C infection and renal disease
2/13/2015 9:30:00 AM | Browse: 1533 | Download: 1580
27
Complementary and alternative medications in hepatitis C infection
9/10/2014 6:38:00 PM | Browse: 1233 | Download: 1174